UnknownNot Applicable

The Predictive and Diagnostic Value of Cystatin C and High Sensitive Troponin

Turkey (Türkiye)172 participantsStarted 2022-03-07

Plain-language summary

Our study is planning to evaluate patients with chronic kidney disease who come to the emergency department with chest pain. Estimated GFR (cisGFR) with cystatin and estimated GFR (creaGFR) with creatinine will be calculated. Symptoms, ECG and troponin values of patients will be evaluated for diagnosis of acute coronary syndrome

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age over 18,
✓. chronic kidney diease having chest pain or equivalent of chest pain (dyspnea, diaphoresis, syncope, nausea, vomiting) -

Exclusion criteria

✕. STEMI,
✕. age less than 18,
✕. missing data,
✕. patients referred to or accepted from another medical facility

What they're measuring

anticipated ACS

Timeframe: time passed until PCI (percutaneous coronary intervention) (pre-intervention) or admission to hospital

exclusion of acs

Timeframe: time passed during emergency department visit until discharge avarage of 3-6 hours

Trial details

NCT IDNCT05303441

SponsorAnkara Diskapi Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-07

Contact for this trial

bedriye müge sönmez, assoc. prof.

+903125962470 mugesonmez06@yahoo.com

View on ClinicalTrials.gov More Acute Coronary Syndrome trials